1. Home
  2. CMPX vs EMO Comparison

CMPX vs EMO Comparison

Compare CMPX & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • EMO
  • Stock Information
  • Founded
  • CMPX 2014
  • EMO 2011
  • Country
  • CMPX United States
  • EMO United States
  • Employees
  • CMPX N/A
  • EMO N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • EMO Investment Managers
  • Sector
  • CMPX Health Care
  • EMO Finance
  • Exchange
  • CMPX Nasdaq
  • EMO Nasdaq
  • Market Cap
  • CMPX 730.9M
  • EMO 863.9M
  • IPO Year
  • CMPX N/A
  • EMO N/A
  • Fundamental
  • Price
  • CMPX $4.03
  • EMO $43.14
  • Analyst Decision
  • CMPX Strong Buy
  • EMO
  • Analyst Count
  • CMPX 7
  • EMO 0
  • Target Price
  • CMPX $14.71
  • EMO N/A
  • AVG Volume (30 Days)
  • CMPX 1.9M
  • EMO 27.1K
  • Earning Date
  • CMPX 11-11-2025
  • EMO 01-01-0001
  • Dividend Yield
  • CMPX N/A
  • EMO 6.70%
  • EPS Growth
  • CMPX N/A
  • EMO N/A
  • EPS
  • CMPX N/A
  • EMO N/A
  • Revenue
  • CMPX N/A
  • EMO N/A
  • Revenue This Year
  • CMPX N/A
  • EMO N/A
  • Revenue Next Year
  • CMPX N/A
  • EMO N/A
  • P/E Ratio
  • CMPX N/A
  • EMO N/A
  • Revenue Growth
  • CMPX N/A
  • EMO N/A
  • 52 Week Low
  • CMPX $1.27
  • EMO $26.42
  • 52 Week High
  • CMPX $4.86
  • EMO $40.17
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 53.07
  • EMO 41.04
  • Support Level
  • CMPX $3.86
  • EMO $42.28
  • Resistance Level
  • CMPX $4.86
  • EMO $43.75
  • Average True Range (ATR)
  • CMPX 0.31
  • EMO 0.88
  • MACD
  • CMPX -0.05
  • EMO 0.11
  • Stochastic Oscillator
  • CMPX 38.43
  • EMO 40.00

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About EMO ClearBridge Energy Midstream Opportunity Fund Inc.

ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.

Share on Social Networks: